13-110242803-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.85-69T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.164 in 1,525,936 control chromosomes in the GnomAD database, including 21,998 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2182 hom., cov: 33)
Exomes 𝑓: 0.16 ( 19816 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0200

Publications

3 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-110242803-A-G is Benign according to our data. Variant chr13-110242803-A-G is described in ClinVar as Benign. ClinVar VariationId is 1242718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.85-69T>C intron_variant Intron 1 of 51 ENST00000375820.10 NP_001836.3
COL4A1NM_001303110.2 linkc.85-69T>C intron_variant Intron 1 of 24 NP_001290039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.85-69T>C intron_variant Intron 1 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.164
AC:
25007
AN:
152120
Hom.:
2183
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.199
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.00768
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.177
Gnomad OTH
AF:
0.152
GnomAD4 exome
AF:
0.164
AC:
225721
AN:
1373698
Hom.:
19816
AF XY:
0.166
AC XY:
114144
AN XY:
688354
show subpopulations
African (AFR)
AF:
0.202
AC:
6362
AN:
31520
American (AMR)
AF:
0.0694
AC:
3094
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3416
AN:
25638
East Asian (EAS)
AF:
0.00536
AC:
211
AN:
39382
South Asian (SAS)
AF:
0.184
AC:
15571
AN:
84546
European-Finnish (FIN)
AF:
0.134
AC:
6869
AN:
51328
Middle Eastern (MID)
AF:
0.180
AC:
1012
AN:
5624
European-Non Finnish (NFE)
AF:
0.174
AC:
179918
AN:
1033684
Other (OTH)
AF:
0.162
AC:
9268
AN:
57378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
8261
16523
24784
33046
41307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6010
12020
18030
24040
30050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.164
AC:
25029
AN:
152238
Hom.:
2182
Cov.:
33
AF XY:
0.160
AC XY:
11889
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.199
AC:
8245
AN:
41532
American (AMR)
AF:
0.102
AC:
1551
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
454
AN:
3468
East Asian (EAS)
AF:
0.00789
AC:
41
AN:
5196
South Asian (SAS)
AF:
0.172
AC:
831
AN:
4826
European-Finnish (FIN)
AF:
0.121
AC:
1283
AN:
10600
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.177
AC:
12038
AN:
68014
Other (OTH)
AF:
0.151
AC:
320
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1081
2162
3243
4324
5405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.163
Hom.:
271
Bravo
AF:
0.163
Asia WGS
AF:
0.0930
AC:
327
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.3
DANN
Benign
0.26
PhyloP100
0.020
PromoterAI
0.030
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41275106; hg19: chr13-110895150; API